Helena F. Florindo

University of Lisbon — Portugal

Immunology and Microbiology · Life Sciences

31h-index4.4kcitations110works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(38), RNA Interference and Gene Delivery(23), Nanoparticle-Based Drug Delivery(16), Nanoplatforms for cancer theranostics(16), Advanced Drug Delivery Systems(15)

Publications110 total

A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery
Biomaterials·2025· 2 citedOpen Access
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment
Journal of Controlled Release·2025· 1 citedOpen Access
Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy
Journal of Controlled Release·2025· 4 citedOpen Access
Abstract 4474: Turning up the heat: nanoimmunotherapy transforming outcomes in breast cancer treatment
Cancer Research·2025· 1 cited
Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy
Journal of Controlled Release·2025· 7 citedOpen Access
Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma
Advanced Materials·2025· 8 citedOpen Access
Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I
Molecular Therapy Oncology·2025· 9 citedOpen Access
Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
Advanced Therapeutics·2025· 1 citedOpen Access
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers
Science Advances·2024· 8 citedOpen Access
Characterizing the Multiple Myeloma Bone Marrow Microenvironment at the Single-Cell Level in a Preclinical Model
Blood·2024
Better, Faster, Stronger: Accelerating <scp>mRNA</scp>‐Based Immunotherapies With Nanocarriers
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology·2024· 5 citedOpen Access
Relative Tumour Volume in Canine Oral Melanoma Staging and Prognosis
Veterinary and Comparative Oncology·2024· 2 citedOpen Access
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024)
Advanced Science·2024Open Access
Contributors
Elsevier eBooks·2024Open Access
Process analytics for the manufacturing of nanomedicines: Challenges and opportunities
Elsevier eBooks·2024· 5 cited
Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
Advanced Therapeutics·2024· 2 citedOpen Access
Editorial: Gateways to the brain: vascular-glial-immune network in health and disease
Frontiers in Cellular Neuroscience·2024· 2 citedOpen Access
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
Advanced Healthcare Materials·2024· 13 citedOpen Access
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Advanced Science·2024· 5 citedOpen Access
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue
Cell Discovery·2024· 20 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Ronit Satchi‐Fainaro(17), Ana I. Matos(14), Carina Peres(12), Liana C. Silva(10), Rita C. Acúrcio(9), Liane I.F. Moura(9), Bárbara Carreira(8), João Conniot(8), Véronique Préat(8), Rogério Gaspar(7), Eva Zupančič(7), Ana S. Viana(7), Luís Graça(7), António J. Almeida(7), Mafalda Videira(6), Anna Scomparin(6), Lídia Gonçalves(6), Sabina Pozzi(5), Vanessa Sainz(5), Joana M. Silva(5)